Heleen Bouman
About
Heleen Bouman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine.
According to data from OpenAlex, Heleen Bouman has authored 31 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 7 papers in Internal Medicine. Recurrent topics in Heleen Bouman's work include Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Coronary Interventions and Diagnostics (9 papers). Heleen Bouman is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Coronary Interventions and Diagnostics (9 papers). Heleen Bouman collaborates with scholars based in Netherlands, Germany and United States. Heleen Bouman's co-authors include Jochem W. van Werkum, Jurriën M. ten Berg, Nicoline J. Breet, Christian M. Hackeng, Ankie M. Harmsze, Vera H.M. Deneer, C. M. Hackeng, Dirk Taubert, Henk J.T. Ruven and Johannes C. Kelder and has published in prestigious journals such as JAMA, Nature Medicine and Journal of the American College of Cardiology.
In The Last Decade
Heleen Bouman
31 papers receiving 2.1k citations
Hit Papers
Peers
Heleen Bouman
Tanja Morath Germany
David S. Small United States
Julia Stegherr Germany
Christian M. Hackeng Netherlands
Jochem W. van Werkum Netherlands
Kathleen Butler United States
Guillaume Cayla France
Francesco Franchi United States
Élodie Drouet France
Christopher D. Payne United States
Citations per year, relative to Heleen Bouman Heleen Bouman (= 1×)
peers
Tanja Morath
Countries citing papers authored by Heleen Bouman
Since
Specialization
Citations
This map shows the geographic impact of Heleen Bouman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heleen Bouman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heleen Bouman more than expected).
Fields of papers citing papers by Heleen Bouman
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Heleen Bouman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heleen Bouman. The network helps show where Heleen Bouman may publish in the future.
Co-authorship network of co-authors of Heleen Bouman
This figure shows the co-authorship network connecting the top 25 collaborators of Heleen Bouman. A scholar is included among the top collaborators of Heleen Bouman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heleen Bouman. Heleen Bouman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Carioni, Paola, Francesco Bellocchio, Frank M. van der Sande, et al.. (2024). The effects of dialysate calcium prescription on mortality outcomes in incident patients on hemodialysis. Clinical Kidney Journal. 17(10). sfae288–sfae288.
2.
Vries, Minka J. A., Heleen Bouman, Renske H. Olie, et al.. (2016). Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients. European Heart Journal - Cardiovascular Pharmacotherapy. 3(1). 11–17.
3.
Breet, Nicoline J., Willem Jan W. Bos, Heleen Bouman, et al.. (2014). The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting. Thrombosis and Haemostasis. 112(12). 1174–1181.
4.
Harmsze, Ankie M., Jochem W. van Werkum, Christian M. Hackeng, et al.. (2012). The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting. Pharmacogenetics and Genomics. 22(3). 169–175.
5.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, et al.. (2011). High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention. Heart. 97(12). 983–990.
6.
Bouman, Heleen, Jochem W. van Werkum, Nicoline J. Breet, et al.. (2011). A case–control study on platelet reactivity in patients with coronary stent thrombosis. Journal of Thrombosis and Haemostasis. 9(5). 909–916.
7.
Harmsze, Ankie M., Jochem W. van Werkum, Patrick C. Souverein, et al.. (2011). Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C19*2 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. Journal of Thrombosis and Haemostasis. 9(10). 1892–1901.
8.
Breet, Nicoline J., Maayke A. Sluman, Jochem W. van Werkum, et al.. (2011). Effect of gender difference on platelet reactivity. Netherlands Heart Journal. 19(11). 451–457.
9.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, et al.. (2011). The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction. Thrombosis and Haemostasis. 106(8). 331–336.
10.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, et al.. (2011). Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?. Netherlands Heart Journal. 19(6). 279–284.
11.
Bouman, Heleen, Edgar Schömig, Jochem W. van Werkum, et al.. (2011). Reply to: "Paraoxonase-1 and clopidogrel efficacy". Nature Medicine. 17(9). 1042–1044.
12.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, Jurriën M. ten Berg, & Christian M. Hackeng. (2010). Platelet function tests for the monitoring of P2Y12 inhibitors. Expert Opinion on Medical Diagnostics. 4(3). 251–265.
13.
Harmsze, Ankie M., Jochem W. van Werkum, Jurriën M. ten Berg, et al.. (2010). CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. European Heart Journal. 31(24). 3046–3053.
14.
Bouman, Heleen, Edgar Schömig, Jochem W. van Werkum, et al.. (2010). Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nature Medicine. 17(1). 110–116.
15.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, et al.. (2010). High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events. Journal of Thrombosis and Haemostasis. 8(10). 2140–2148.
16.
Werkum, Jochem W. van, Heleen Bouman, Nicoline J. Breet, Jurriën M. ten Berg, & Christian M. Hackeng. (2010). The Cone-and-Plate(let) analyzer is not suitable to monitor clopidogrel therapy: A comparison with the flowcytometric VASP assay and optical aggregometry. Thrombosis Research. 126(1). 44–49.
17.
Bouman, Heleen, et al.. (2009). Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects. Netherlands Heart Journal. 17(5). 195–198.
18.
Bouman, Heleen, Jochem W. van Werkum, Nicoline J. Breet, et al.. (2009). Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel. Journal of Thrombosis and Haemostasis. 8(3). 482–488.
19.
Bouman, Heleen, et al.. (2009). The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests. Thrombosis and Haemostasis. 102(10). 719–727.
20.
Bouman, Heleen & Jan H. Teuben. (1976). Synthesis and properties of alkyldicyclopentadienyl-vanadium(III) compounds. Journal of Organometallic Chemistry. 110(3). 327–330.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Tanja Morath Breakdown of academic impact, for papers by David S. Small Breakdown of academic impact, for papers by Julia Stegherr Breakdown of academic impact, for papers by Christian M. Hackeng Breakdown of academic impact, for papers by Jochem W. van Werkum Breakdown of academic impact, for papers by Kathleen Butler Breakdown of academic impact, for papers by Guillaume Cayla Breakdown of academic impact, for papers by Francesco Franchi Breakdown of academic impact, for papers by Élodie Drouet Breakdown of academic impact, for papers by Christopher D. Payne